Missing content? – Request curation!
Request curation for specific Genes, Variants, or PubMed publications.
Have questions, comments, or suggestions? - Let us know!
Email us at : ckbsupport@genomenon.com
NCT ID | NCT04162756 |
Title | Study of KTE-X19 for the Treatment of Individuals With Relapsed/Refractory B-Cell Malignancies (ZUMA-18) |
Acronym | ZUMA-18 |
Recruitment | Approved for marketing |
Gender | both |
Phase | Expanded access |
Variant Requirements | No |
Sponsors | Kite, A Gilead Company |
Indications | |
Therapies | |
Age Groups: | senior | adult |
Covered Countries | USA |
Facility | Status | City | State | Zip | Country | Details |
---|---|---|---|---|---|---|
Stanford Cancer Institute | Stanford | California | 94305 | United States | Details | |
Colorado Blood Cancer Institute | Denver | Colorado | 80218 | United States | Details | |
Moffitt Cancer Center | Tampa | Florida | 33612 | United States | Details | |
Dana-Farber Cancer Institute | Boston | Massachusetts | 02215 | United States | Details | |
John Theurer Cancer Center at Hackensack University Medical Center | Hackensack | New Jersey | 07601 | United States | Details | |
Cleveland Clinic | Cleveland | Ohio | 44195 | United States | Details | |
Sarah Cannon Research Institute | Nashville | Tennessee | 37203 | United States | Details | |
Henry-Joyce Cancer Clinic | Nashville | Tennessee | 37232 | United States | Details | |
The University of TX MD Anderson Cancer Center | Houston | Texas | 77030 | United States | Details |